Irfan M. Admani

Irfan Admani practices at Bergen New Bridge Medical Center in Paramus, New Jersey, part of Bergen County, New Jersey.

Irfan Admani's NPI, 1043228588, was assigned on August 3, 2006. Irfan Admani graduated from St. George's University School of Medicine in 1996. Irfan Admani holds New Jersey license 25MA07010400.

Irfan Admani's primary practice is Bergen New Bridge Medical Center, at 230 East Ridgewood Ave, Paramus, NJ 07652 in Bergen County. The practice phone is (201) 967-4000.

Irfan Admani's primary practice is Bergen New Bridge Medical Center in Paramus, New Jersey, part of Bergen County, New Jersey. Irfan Admani is also affiliated with Hackensack University Medical Center. The medical group on file is Hackensack Meridian Medical Group. Dmand AI also links Irfan Admani to 2 more hospitals, 3 group practices and clinics, 2 medical groups and 1 physician office, each named with a free account. Irfan Admani's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Irfan Admani practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Irfan Admani's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Irfan Admani is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Irfan Admani's licenses on file in 2 states: New Jersey and West Virginia.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension, coronary artery disease and heart failure among the conditions Irfan Admani treats.

CMS data shows 2,732 Medicare services from Irfan Admani across 16 procedure codes in 2024, for 670 Medicare patients. Medicare paid $286,952 for them.

CMS counts 670 Medicare patients who saw Irfan Admani in 2024. The largest group is 65 to 74, with 264 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Irfan Admani's median patient age at 53, with 43% women.

In 2024, Irfan Admani wrote 2,146 Medicare Part D claims for 283 patients. 82% of them were for generic drugs. CMS names the drug for 1,936 of them, across 34 drugs with 11 or more claims each, at $353,503 in total drug cost. In 2023, CMS named 1,299 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Irfan Admani for performance year 2024, reported as part of a group. Irfan Admani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Irfan Admani in 2016. Irfan Admani's most frequent co-authors are Haroon Ahmed Faraz, MD, Atish Pratap Mathur, MD and Joseph E. Parrillo, MD.

Dmand AI links Irfan Admani to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Coronary Artery Disease and Coronary Disease.

CMS Open Payments shows 231 general payments to Irfan Admani from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Medtronic Vascular, Inc. paid the most, $5,828. It also lists 2 research payments totaling $276 from 2017 to 2019.

Dmand AI lists 1 award for Irfan Admani.

Irfan Admani graduated from St. George's University School of Medicine in 1996. Irfan Admani is a member of ACC.

Irfan Admani is in network with 9 carriers, including Aetna, Elevance and Horizon Blue Cross Blue Shield of New Jersey. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.